A peptide derived from interleukin-10 exhibits potential anticancer activity and can facilitate cell targeting of gold nanoparticles loaded with anticancer therapeutics
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
A peptide derived from interleukin-10 exhibits potential anticancer activity and can facilitate cell targeting of gold nanoparticles loaded with anticancer therapeutics ; volume:6 ; number:1 ; day:15 ; month:12 ; year:2023 ; pages:1-12 ; date:12.2023
Communications chemistry ; 6, Heft 1 (15.12.2023), 1-12, 12.2023
- Urheber
-
Chang, Chun-Chun
Yang, Chin-Hao
Chuang, Chin-Hsien
Jiang, Shinn-Jong
Hwang, Yin-Min
Liou, Je-Wen
Hsu, Hao-Jen
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s42004-023-01079-x
- URN
-
urn:nbn:de:101:1-2024030107395341012799
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:01 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Chang, Chun-Chun
- Yang, Chin-Hao
- Chuang, Chin-Hsien
- Jiang, Shinn-Jong
- Hwang, Yin-Min
- Liou, Je-Wen
- Hsu, Hao-Jen
- SpringerLink (Online service)
Ähnliche Objekte (12)
Targeting CDK9 for anti-cancer therapeutics
Mitophagy in carcinogenesis, drug resistance and anticancer therapeutics
PARP inhibitors: current status and implications for anticancer therapeutics
Biocompatible nanoreactors of catalase and nanozymes for anticancer therapeutics
Recent developments in mushrooms as anti-cancer therapeutics: a review
Akt inhibitors: mechanism of action and implications for anticancer therapeutics
Hydroxycamptothecin-loaded nanoparticles enhance target drug delivery and anticancer effect
Adjuvant-loaded protein-based nanocapsules induce effective anti-cancer immunity
Pharmacokinetic characteristics and anticancer effects of 5-Fluorouracil loaded nanoparticles
Mining the deep Red-Sea brine pool microbial community for anticancer therapeutics
Anticancer activity of drug-loaded calcium phosphate nanocomposites against human osteosarcoma
Heterocyclic anticancer agents
Targeting CDK9 for anti-cancer therapeutics
Mitophagy in carcinogenesis, drug resistance and anticancer therapeutics
PARP inhibitors: current status and implications for anticancer therapeutics
Biocompatible nanoreactors of catalase and nanozymes for anticancer therapeutics
Recent developments in mushrooms as anti-cancer therapeutics: a review
Akt inhibitors: mechanism of action and implications for anticancer therapeutics
Hydroxycamptothecin-loaded nanoparticles enhance target drug delivery and anticancer effect
Adjuvant-loaded protein-based nanocapsules induce effective anti-cancer immunity
Pharmacokinetic characteristics and anticancer effects of 5-Fluorouracil loaded nanoparticles
Mining the deep Red-Sea brine pool microbial community for anticancer therapeutics
Anticancer activity of drug-loaded calcium phosphate nanocomposites against human osteosarcoma
Heterocyclic anticancer agents
Targeting CDK9 for anti-cancer therapeutics
Mitophagy in carcinogenesis, drug resistance and anticancer therapeutics
PARP inhibitors: current status and implications for anticancer therapeutics
Biocompatible nanoreactors of catalase and nanozymes for anticancer therapeutics
Recent developments in mushrooms as anti-cancer therapeutics: a review
Akt inhibitors: mechanism of action and implications for anticancer therapeutics
Hydroxycamptothecin-loaded nanoparticles enhance target drug delivery and anticancer effect
Adjuvant-loaded protein-based nanocapsules induce effective anti-cancer immunity
Pharmacokinetic characteristics and anticancer effects of 5-Fluorouracil loaded nanoparticles
Mining the deep Red-Sea brine pool microbial community for anticancer therapeutics
Anticancer activity of drug-loaded calcium phosphate nanocomposites against human osteosarcoma